実験動物モデル、3D培養、オルガノイド。世界市場Laboratory Animal Models, 3D Cultures and Organoids: Global Markets 報告書の範囲 本レポートでは、動物モデル市場、3D培養市場、オルガノイド市場の3つの世界市場を解説しています。特にオルガノイド市場については、レポートの別章で異なるセグメントの市場推定を行い、より詳... もっと見る
サマリー報告書の範囲本レポートでは、動物モデル市場、3D培養市場、オルガノイド市場の3つの世界市場を解説しています。特にオルガノイド市場については、レポートの別章で異なるセグメントの市場推定を行い、より詳細に記述しています。 レポートには以下の内容が含まれます。 - 26のデータテーブルと28の追加テーブル - 実験動物モデル、3D細胞培養、オルガノイドの世界市場に関する最新レビューと業界内の分析 - 2019年から2021年の歴史的な市場収益データ、2022年の推定値、2027年までの年間複合成長率(CAGR)の予測による世界市場動向の分析 - 産業構造の現状、新規技術のアップデート、オルガノイドの統合と厳しい規制制約を取り巻く問題、進行中の研究活動、市場全体に対するCOVID-19の影響についてのハイライト - オルガノイドの実際の市場規模の推定と市場予測(百万ドル単位)、および製品タイプ、用途、地域別に対応する市場シェア分析 - アメリカ、カナダ、ドイツ、イギリス、フランス、イタリア、スペイン、日本、オーストラリア、中国、インドなどにおけるオルガノイドの地域別・国別データおよび分析 - 毒性試験や化学物質の安全性・代謝評価に動物が使用される基礎研究、生物医学、その他の産業に大きく影響する現在のトレンドに関する情報 - バイオ医薬品産業における3D細胞培養、動物モデル、オルガノイドのメリットとデメリットを総合的に検討した市場機会の分析 - オルガノイドに関する特許と特許出願のレビュー、および世界市場における新たな展開のレビュー - 主要な利害関係者の特定と、最近の開発およびセグメント別の収益に基づく競争状況の分析 - Cellesce Ltd.、Corning Inc.、Merck KGaA、Thermo Fisher Scientific Inc.、Hubrecht Organoid Technology(HUB)、STEMCELL Technologies Incなど、オルガノイド市場の主要企業の詳細な企業プロフィール。 目次Table of ContentsChapter 1 Introduction Background Study Goals and Objectives Reasons for Doing This Study Scope of Report What's New in This Update? Information Sources and Methodology Geographic Breakdown Analyst's Credentials BCC Custom Research Related BCC Research Reports Chapter 2 Summary and Highlights Chapter 3 Animal Model Market Technology Background Methods of Animal Model and 3D Cell Culture Modification Physical and Chemical Mutations Targeted Mutations Other Technologies Laboratory Animal Models Market Definition Animal Model Lines Common Species of Laboratory Animals Chapter 4 Impact of COVID-19 on the Global Market for Organoids Overview Impact of COVID-19 on Organoids Conclusion Chapter 5 Market Dynamics Market Drivers Increasing Emphasis on Developing Alternative Approaches to Animal Testing Rising Demand for Tumor Modelling and Biobanking to Drive Market Growth Increasing Adoption of the Organoid Technology for Wide Range of Applications Market Restraints Stringent Government Regulatory Setting in Research and Development of Cell Cultures and Stem Cells Concerns Associated with the Integration of Organoids into Current Workflows Market Opportunities Increasing Applications of Organoids in Drug Development, Personalized Medicine and Transplantational Medicine Chapter 6 3D Cell Technology Background 3D Cell Cultures Spheroids 2D Cultures vs. 2.5D Cultures vs. 3D Cultures Scaffold-Based and Scaffold-Free 3D Cell Cultures Scaffold-Free 3D Cell Cultures Scaffold-Based 3D Cell Cultures Tissue Engineering and Bioprinting 3D Bioprinting Technology Types of Bioprinting Methods Microfluidic Organ-on-Chip Platforms Types of Organ-on-Chip Devices Chapter 7 Market Breakdown by Organ Type Global Market for Organoids, by Organ Type Intestine Market Size and Forecast Liver Market Size and Forecast Stomach Market Size and Forecast Pancreas Market Size and Forecast Lung (Pulmonary) Market Size and Forecast Kidney Market Size and Forecast Others Cardiac Organoids Cancer Organoids Market Size and Forecast Chapter 8 Market Breakdown by Application Global Market for Organoids, by Application Developmental Biology Market Size and Forecast Drug Discovery and Personalized Medicine Market Size and Forecast Regenerative Medicine Market Size and Forecast Pathology of Infectious Disease Market Size and Forecast Drug Toxicity and Efficacy Testing Market Size and Forecast Chapter 9 Market Breakdown by Region Global Market for Organoids, by Region North America U.S. Canada Europe Germany France U.K. Italy Spain Rest of Europe Asia-Pacific China Japan Australia India Rest of Asia-Pacific Rest of the World Market Size and Forecast Chapter 10 Patent Review/New Developments Chapter 11 Analysis of Market Opportunities Market Opportunities: Animal Models Market Opportunities: 3D Cell Culture Segment Organs-on-Chip Organoids Bioprinting Advantages and Disadvantages of 3D Cell Cultures and Animal Models Animal Models 3D Cell Cultures in General Organoids Organs-on-Chip Chapter 12 Competitive Landscape Chapter 13 Profiles of Companies and Important Institutions Animal Model Companies ALPHA GENESIS INC. CHARLES RIVER LABORATORIES INTERNATIONAL INC. ENVIGO GENOWAY S.A. LABCORP DRUG DEVELOPMENT (COVANCE INC.) THE JACKSON LABORATORY JANVIER LABS OAK HILL GENETICS PRIMGEN TACONIC BIOSCIENCES TRANSGENIC INC. TRANSPOSAGEN BIOPHARMACEUTICALS INC. Bioprinting and Regenerative Medicine Companies ALLEVI ASPECT BIOSYSTEMS LTD. BIOINK SOLUTIONS INC. CELLINK INC. COLLPLANT HOLDINGS LTD. EAST RIVER BIOSOLUTIONS/XYLYX BIO EPIBONE MATTEK CORP. NANO 3D BIOSCIENCES INC. ORGANOVO HOLDINGS INC. PEPGEL LLC REGENHU TEVIDO BIODEVICES INC. TISSUSE GMBH Organ-on-Chip Companies AXOSIM EMULATE INC. KIRKSTALL LTD. MICRONIT MICROTECHNOLOGIES MIMETAS TARA BIOSYSTEMS INC. Organoid Companies 3DNAMICS INC. CELLESCE CINCINNATI CHILDREN’S HOSPITAL MEDICAL CENTER CROWN BIOSCIENCE CORNING INC. DEFINIGEN HUBRECHT ORGANOID TECHNOLOGY (HUB) MERCK KGAA R&D SYSTEMS INC. STEMCELL TECHNOLOGIES INC. THERMO FISHER SCIENTIFIC TREVIGEN INC. (BIO-TECHNE) Other 3D Cell Culture Companies 3D BIOTEK LLC ADVANCED BIOMATRIX INC. HORIZON DISCOVERY LTD. INSPHERO INC. PROMOCELL GMBH REPROCELL INC. SYNTHECON INC.
SummaryReport Scope: Table of ContentsTable of ContentsChapter 1 Introduction Background Study Goals and Objectives Reasons for Doing This Study Scope of Report What's New in This Update? Information Sources and Methodology Geographic Breakdown Analyst's Credentials BCC Custom Research Related BCC Research Reports Chapter 2 Summary and Highlights Chapter 3 Animal Model Market Technology Background Methods of Animal Model and 3D Cell Culture Modification Physical and Chemical Mutations Targeted Mutations Other Technologies Laboratory Animal Models Market Definition Animal Model Lines Common Species of Laboratory Animals Chapter 4 Impact of COVID-19 on the Global Market for Organoids Overview Impact of COVID-19 on Organoids Conclusion Chapter 5 Market Dynamics Market Drivers Increasing Emphasis on Developing Alternative Approaches to Animal Testing Rising Demand for Tumor Modelling and Biobanking to Drive Market Growth Increasing Adoption of the Organoid Technology for Wide Range of Applications Market Restraints Stringent Government Regulatory Setting in Research and Development of Cell Cultures and Stem Cells Concerns Associated with the Integration of Organoids into Current Workflows Market Opportunities Increasing Applications of Organoids in Drug Development, Personalized Medicine and Transplantational Medicine Chapter 6 3D Cell Technology Background 3D Cell Cultures Spheroids 2D Cultures vs. 2.5D Cultures vs. 3D Cultures Scaffold-Based and Scaffold-Free 3D Cell Cultures Scaffold-Free 3D Cell Cultures Scaffold-Based 3D Cell Cultures Tissue Engineering and Bioprinting 3D Bioprinting Technology Types of Bioprinting Methods Microfluidic Organ-on-Chip Platforms Types of Organ-on-Chip Devices Chapter 7 Market Breakdown by Organ Type Global Market for Organoids, by Organ Type Intestine Market Size and Forecast Liver Market Size and Forecast Stomach Market Size and Forecast Pancreas Market Size and Forecast Lung (Pulmonary) Market Size and Forecast Kidney Market Size and Forecast Others Cardiac Organoids Cancer Organoids Market Size and Forecast Chapter 8 Market Breakdown by Application Global Market for Organoids, by Application Developmental Biology Market Size and Forecast Drug Discovery and Personalized Medicine Market Size and Forecast Regenerative Medicine Market Size and Forecast Pathology of Infectious Disease Market Size and Forecast Drug Toxicity and Efficacy Testing Market Size and Forecast Chapter 9 Market Breakdown by Region Global Market for Organoids, by Region North America U.S. Canada Europe Germany France U.K. Italy Spain Rest of Europe Asia-Pacific China Japan Australia India Rest of Asia-Pacific Rest of the World Market Size and Forecast Chapter 10 Patent Review/New Developments Chapter 11 Analysis of Market Opportunities Market Opportunities: Animal Models Market Opportunities: 3D Cell Culture Segment Organs-on-Chip Organoids Bioprinting Advantages and Disadvantages of 3D Cell Cultures and Animal Models Animal Models 3D Cell Cultures in General Organoids Organs-on-Chip Chapter 12 Competitive Landscape Chapter 13 Profiles of Companies and Important Institutions Animal Model Companies ALPHA GENESIS INC. CHARLES RIVER LABORATORIES INTERNATIONAL INC. ENVIGO GENOWAY S.A. LABCORP DRUG DEVELOPMENT (COVANCE INC.) THE JACKSON LABORATORY JANVIER LABS OAK HILL GENETICS PRIMGEN TACONIC BIOSCIENCES TRANSGENIC INC. TRANSPOSAGEN BIOPHARMACEUTICALS INC. Bioprinting and Regenerative Medicine Companies ALLEVI ASPECT BIOSYSTEMS LTD. BIOINK SOLUTIONS INC. CELLINK INC. COLLPLANT HOLDINGS LTD. EAST RIVER BIOSOLUTIONS/XYLYX BIO EPIBONE MATTEK CORP. NANO 3D BIOSCIENCES INC. ORGANOVO HOLDINGS INC. PEPGEL LLC REGENHU TEVIDO BIODEVICES INC. TISSUSE GMBH Organ-on-Chip Companies AXOSIM EMULATE INC. KIRKSTALL LTD. MICRONIT MICROTECHNOLOGIES MIMETAS TARA BIOSYSTEMS INC. Organoid Companies 3DNAMICS INC. CELLESCE CINCINNATI CHILDREN’S HOSPITAL MEDICAL CENTER CROWN BIOSCIENCE CORNING INC. DEFINIGEN HUBRECHT ORGANOID TECHNOLOGY (HUB) MERCK KGAA R&D SYSTEMS INC. STEMCELL TECHNOLOGIES INC. THERMO FISHER SCIENTIFIC TREVIGEN INC. (BIO-TECHNE) Other 3D Cell Culture Companies 3D BIOTEK LLC ADVANCED BIOMATRIX INC. HORIZON DISCOVERY LTD. INSPHERO INC. PROMOCELL GMBH REPROCELL INC. SYNTHECON INC.
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野(医療)の最新刊レポート
BCC Research社のその他分野での最新刊レポート本レポートと同じKEY WORD(laboratory)の最新刊レポート
よくあるご質問BCC Research社はどのような調査会社ですか?BCCリサーチ(BCC Research)は1971年に設立され、様々な業界経験を持つアナリストと編集者によりトップクラスの市場情報源を長年提供している調査会社です。 設立初期は先端材料とプラ... もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|